Forskningsfinansiering från USA

This page in English

Ett stort antal forskningsprojekt vid Karolinska Institutet får finansiellt stöd från USA. 2016 kom cirka 40 miljoner kronor från amerikanska federala finansiärer, inklusive National Institutes of Health (NIH), och över 38 miljoner kom från privata stiftelser i landet.

Anslag 2010-2016 (i miljoner svenska kronor)
Årtal Statliga
2010 45,9 25,0 70,9
2011 21,6 22,1 43,7
2012 25,2 33,1 58,3
2013 21,3 45,6 66,9
2014 22,5 46,1 68,6
2015 32,8 42,4 75,2
2016 40,6 38,2 78,8

Federala statliga anslag till enskilda KI-forskare

NIH – 2016

  • Ahmed Elewa (F32/Prime) – Discovering signature genes and developing expression markers for blastema cells
  • David Mataix-Cols (R01/Sub) – OCD: Novel Comparative Genomic Approaches to Identify Disease and Treatment Mechanisms.
  • Elias Arnér (R21/Sub) – Redox regulation in the hepatostat.
  • Fredrik Wiklund (R01/Sub) – The Genetic Basis of Aggressive Prostate Cancer: The Role of Rare Variation.
  • Konstantinos Meletis (R21/Sub) – Development of a whole-brain cellular mapping approach in a genetic model of autism and intellectual disability.
  • Nancy Pedersen (R56/Sub) – Gene-Environment Interplay of Social contexts and Aging-Related Outcomes.
  • Ujjwal Neogi (R01/Sub) – Reverse Transcriptase Multi-Class Drug Resistance and Rilpivirine Susceptibility in Diverse HIV-1 Subtypes.

NIH – 2015

  • Johan Sandberg (R01/Sub) – Intestinal MAIT Cells in HIV Infection.
  • Karin Broberg (R01/Sub) – Factors modifying the toxicity of methylmercury in a fish-eating population.
  • Kristina Gemzell Danielsson (Federal contract/Sub) – Clinical evaluation of nestorone gel and testosterone gel for male contraception.
  • Martin Neovius (R01/Sub) – Benefits, Risks & Costs of Bariatric Surgery: Register-Enriched Cohort Studies.
  • Mikael Landén (R01/Sub) –1/3 Genetic analysis of the international cohort collection for bipolar disorder.
  • Marianne Schultzberg (R21/Sub) – Resolving Factors in Alzheimers Disease.

NIH – 2014

  • Christina Dalman (R21/Sub) – Early life vitamin D levels and risk of autism spectrum disorders.
  • Christina Hultman (R01/Sub) – Population-based autism genetics & environment study.
  • Gunilla Karlsson Hedestam (P01/Sub) – High resolution analysis of ENV-directed B cells to accelerate vaccine design.
  • Henrik Larsson (R01/Sub) – Risks and Benefits of ADHD Medication for Psychiatric and Neurologic Problems.
  • Kristina Broliden (U19/Sub) – Griffithsin-based Rectal Microbicides for PREvention of Viral ENTry (PREVENT).
  • Lennart Hammarström (R01/Sub) – IGA Nephropathy: Interventions with generation of nephritogenic immune complexes.
  • Martin Eklund (U01/Sub) – Modeling the impact of targeted therapy based on breast cancer subtypes.
  • Ole Kiehn (R01/Sub) – Spinal cord neural circuits for left-right and flexor-extensor coordination.

Department of Defense (DoD)

2016: Barbara Canlon (CDMRP/Prime) – Chronopharmacological Interventions for the Successful Treatment of Noise-Induced Hearing Loss.

2015: Theresa Vincent (CDMRP/Sub) – Targeting Breast Cancer Metastasis through Selective Inhibition of RNA Polymerase I.


Finansiering från privata stiftelser till enskilda KI-forskare


Bill & Melinda Gates Foundation: Karin Loré (Sub) – Structure Based Immunogen Design at UWIPD.


Jeffrey Modell Foundation: Lennart Hammarström (Sub) 

Patient-Centered Outcomes Research Institute (PCORI): Fredrik Piehl (Prime) – Rituximab in Multiple Sclerosis: A Comparative Study on Effectiveness, Safety, and Patient-Reported Outcomes.


Bill & Melinda Gates Foundation:

CHDI Foundation Inc: Christer Halldin

The Myositis Association: Ingrid Lundberg

The Vallee Foundation: Rickard Sandberg (Vallee Scholar) – The nature of allelic gene expression in vivo